Archives

  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br Teoh AY Chiu PW Yeung

    2022-05-06


    11. Teoh AY, Chiu PW, Yeung WK, Liu SY, Wong SK, Ng EK. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carci-noma of the esophagus: results from a randomized controlled trial. Ann Oncol 2013;24:165–71.
    12. Chiu PW, Chan AC, Leung SF, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005;9:794–802.
    13. Carstens H, Albertsson M, Friesland S, et al. A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer. J Clin Oncol 2007;25(Suppl):4530.
    14. Pottgen C, Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer—a meta-analysis of the randomized trials. Cancer Treat Rev 2012;38: 599–604.
    15. Karran A, Blake P, Chan D, et al. Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy. Br J Surg 2014;101:502–10. 16. Motoori M, Yano M, Ishihara R, et al. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Ann Surg Oncol 2012;19:2135–41.
    17. Matsuda S, Takeuchi H, Kawakubo H, et al. Correlation be-tween intense postoperative α-CEHC and survival of esophageal cancer patients who underwent transthoracic esophagectomy. Ann Surg Oncol 2015;22: 4453–60.
    18. Hironaka S, Ohtsu A, Boku N, et al. Nonrandomized com-parison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003;57:425–33.
    19. Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 1999;45: 265–70.
    20. Yamashita H, Okuma K, Seto Y, et al. A retrospective com-parison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery  for clinical stage II-III esophageal carcinoma. J Surg Oncol 2009;100:435–41.
    21. Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, Lai MS. Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review. Jpn J Clin Oncol 2015;45:291–6.
    22. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–4. 23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373–83.
    24. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011;12:681–92.
    25. Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol 2014;32:2416–22.
    26. Lin WC, Ding YF, Hsu HL, et al. Value and application of trimodality therapy or definitive concurrent chemo-radiotherapy in thoracic esophageal squamous cell carci-noma. Cancer 2017;123:3904–15.
    27. Dikken JL, Dassen AE, Lemmens VE, et al. Effect of hospital volume on postoperative mortality and survival after oeso-phageal and gastric cancer surgery in the Netherlands be-tween 1989 and 2009. Eur J Cancer 2012;48:1004–13.
    28. Coupland VH, Lagergren J, Luchtenborg€ M, et al. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a Repetition frequency population-based study in England, 2004-2008. Gut 2013;62:961–6.
    29. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg 2007;245:777–83. 30. Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg 2007;94:578–84.
    31. Rouvelas I, Lindblad M, Zeng W, Viklund P, Ye W, Lagergren J. Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg 2007;142:113–7. 32. Hsu PK, Chen HS, Wu SC, et al. Impact of hospital volume on long-term survival after resection for oesophageal cancer: a population-based study in Taiwan. Eur J Cardiothorac Surg 2014;46:e127–35.
    33. Hsu PK, Chen HS, Wang BY, et al. Hospital type-and vol-ume-outcome relationships in esophageal cancer patients receiving non-surgical treatments. World J Gastroenterol 2015;21:1234–42.